REGN logo

REGN Cash from operations

annual CFO:

$4.42B-$173.50M(-3.78%)
December 31, 2024

Summary

  • As of today (May 29, 2025), REGN annual cash flow from operations is $4.42 billion, with the most recent change of -$173.50 million (-3.78%) on December 31, 2024.
  • During the last 3 years, REGN annual CFO has fallen by -$2.66 billion (-37.58%).
  • REGN annual CFO is now -37.58% below its all-time high of $7.08 billion, reached on December 31, 2021.

Performance

REGN Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

quarterly CFO:

$1.05B-$217.70M(-17.24%)
March 31, 2025

Summary

  • As of today (May 29, 2025), REGN quarterly cash flow from operations is $1.05 billion, with the most recent change of -$217.70 million (-17.24%) on March 31, 2025.
  • Over the past year, REGN quarterly CFO has dropped by -$467.40 million (-30.90%).
  • REGN quarterly CFO is now -69.38% below its all-time high of $3.41 billion, reached on September 30, 2021.

Performance

REGN quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

TTM CFO:

$3.95B-$467.40M(-10.57%)
March 31, 2025

Summary

  • As of today (May 29, 2025), REGN TTM cash flow from operations is $3.95 billion, with the most recent change of -$467.40 million (-10.57%) on March 31, 2025.
  • Over the past year, REGN TTM CFO has dropped by -$785.80 million (-16.58%).
  • REGN TTM CFO is now -53.57% below its all-time high of $8.51 billion, reached on March 31, 2022.

Performance

REGN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

REGN Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.8%-30.9%-16.6%
3 y3 years-37.6%-50.3%-53.6%
5 y5 years+81.9%+49.7%+77.2%

REGN Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.6%at low-50.3%+195.2%-53.6%at low
5 y5-year-37.6%+81.9%-69.4%+511.0%-53.6%+81.8%
alltimeall time-37.6%+3220.0%-69.4%+511.0%-53.6%+1606.1%

REGN Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.05B(-17.2%)
$3.95B(-10.6%)
Dec 2024
$4.42B(-3.8%)
$1.26B(-2.2%)
$4.42B(+4.1%)
Sep 2024
-
$1.29B(+264.7%)
$4.25B(+4.3%)
Jun 2024
-
$354.00M(-76.6%)
$4.07B(-14.1%)
Mar 2024
-
$1.51B(+38.8%)
$4.74B(+3.2%)
Dec 2023
$4.59B(-8.4%)
$1.09B(-2.2%)
$4.59B(-12.1%)
Sep 2023
-
$1.11B(+9.0%)
$5.22B(+10.2%)
Jun 2023
-
$1.02B(-25.2%)
$4.74B(+10.7%)
Mar 2023
-
$1.37B(-20.5%)
$4.28B(-14.6%)
Dec 2022
$5.01B(-29.2%)
$1.72B(+173.5%)
$5.01B(-11.5%)
Sep 2022
-
$628.90M(+11.4%)
$5.67B(-32.9%)
Jun 2022
-
$564.40M(-73.1%)
$8.45B(-0.7%)
Mar 2022
-
$2.10B(-11.4%)
$8.51B(+20.2%)
Dec 2021
$7.08B(+170.5%)
$2.37B(-30.5%)
$7.08B(+19.2%)
Sep 2021
-
$3.41B(+444.7%)
$5.94B(+161.4%)
Jun 2021
-
$626.70M(-6.3%)
$2.27B(-12.2%)
Mar 2021
-
$668.50M(-45.7%)
$2.59B(-1.1%)
Dec 2020
$2.62B(+7.7%)
$1.23B(-584.1%)
$2.62B(+20.4%)
Sep 2020
-
-$254.30M(-127.0%)
$2.17B(-27.2%)
Jun 2020
-
$943.40M(+35.2%)
$2.99B(+33.8%)
Mar 2020
-
$698.00M(-11.4%)
$2.23B(-8.2%)
Dec 2019
$2.43B(+10.7%)
$787.40M(+41.3%)
$2.43B(+2.5%)
Sep 2019
-
$557.30M(+196.0%)
$2.37B(+4.6%)
Jun 2019
-
$188.30M(-79.0%)
$2.27B(-8.3%)
Mar 2019
-
$897.00M(+23.1%)
$2.47B(+12.7%)
Dec 2018
$2.20B(+67.9%)
$728.80M(+60.9%)
$2.20B(+8.0%)
Sep 2018
-
$452.90M(+14.8%)
$2.03B(+1.9%)
Jun 2018
-
$394.60M(-36.2%)
$2.00B(+27.1%)
Mar 2018
-
$618.80M(+9.1%)
$1.57B(+20.1%)
Dec 2017
$1.31B(-12.0%)
$566.94M(+36.7%)
$1.31B(+15.6%)
Sep 2017
-
$414.83M(-1457.0%)
$1.13B(-17.3%)
Jun 2017
-
-$30.57M(-108.6%)
$1.37B(-23.9%)
Mar 2017
-
$355.90M(-8.8%)
$1.80B(+20.9%)
Dec 2016
$1.49B(+11.7%)
$390.38M(-40.0%)
$1.49B(+7.9%)
Sep 2016
-
$651.03M(+63.0%)
$1.38B(-14.9%)
Jun 2016
-
$399.50M(+788.0%)
$1.62B(+9.6%)
Mar 2016
-
$44.99M(-84.0%)
$1.48B(+11.0%)
Dec 2015
$1.33B(+76.9%)
$281.82M(-68.4%)
$1.33B(+6.7%)
Sep 2015
-
$892.85M(+246.3%)
$1.25B(+140.5%)
Jun 2015
-
$257.83M(-353.5%)
$518.60M(-13.2%)
Mar 2015
-
-$101.73M(-151.3%)
$597.18M(-20.6%)
Dec 2014
$752.43M(+27.8%)
$198.18M(+20.6%)
$752.43M(-10.0%)
Sep 2014
-
$164.32M(-51.2%)
$835.99M(+9.4%)
Jun 2014
-
$336.41M(+528.5%)
$764.12M(+37.5%)
Mar 2014
-
$53.53M(-81.0%)
$555.88M(-5.6%)
Dec 2013
$588.60M(-888.8%)
$281.73M(+204.7%)
$588.60M(+47.1%)
Sep 2013
-
$92.45M(-27.9%)
$400.05M(+31.1%)
Jun 2013
-
$128.16M(+48.6%)
$305.21M(+209.3%)
Mar 2013
-
$86.25M(-7.4%)
$98.67M(-232.2%)
Dec 2012
-$74.61M(-47.3%)
$93.19M(-4012.0%)
-$74.61M(-65.8%)
Sep 2012
-
-$2.38M(-97.0%)
-$218.12M(-16.9%)
Jun 2012
-
-$78.38M(-10.0%)
-$262.47M(+20.3%)
Mar 2012
-
-$87.04M(+73.0%)
-$218.14M(+54.0%)
Dec 2011
-$141.68M(-242.8%)
-$50.32M(+7.7%)
-$141.68M(+7.2%)
Sep 2011
-
-$46.73M(+37.3%)
-$132.22M(-273.9%)
Jun 2011
-
-$34.05M(+221.8%)
$76.02M(-22.6%)
Mar 2011
-
-$10.58M(-74.1%)
$98.22M(-1.0%)
Dec 2010
$99.22M(-237.4%)
-$40.85M(-125.3%)
$99.22M(+5.9%)
Sep 2010
-
$161.50M(-1462.9%)
$93.67M(-220.6%)
Jun 2010
-
-$11.85M(+23.7%)
-$77.65M(+16.9%)
Mar 2010
-
-$9.58M(-79.4%)
-$66.43M(-8.0%)
Dec 2009
-$72.23M(-18.9%)
-$46.40M(+372.4%)
-$72.23M(+17.1%)
Sep 2009
-
-$9.82M(+1476.6%)
-$61.67M(-34.0%)
Jun 2009
-
-$623.00K(-95.9%)
-$93.39M(+7.9%)
Mar 2009
-
-$15.38M(-57.1%)
-$86.57M(-2.8%)
Dec 2008
-$89.09M
-$35.84M(-13.7%)
-$89.09M(+3567.6%)
Sep 2008
-
-$41.55M(-770.4%)
-$2.43M(-108.5%)
DateAnnualQuarterlyTTM
Jun 2008
-
$6.20M(-134.6%)
$28.42M(+51.9%)
Mar 2008
-
-$17.90M(-135.2%)
$18.71M(-31.6%)
Dec 2007
$27.37M(+18.6%)
$50.82M(-574.9%)
$27.37M(-8.3%)
Sep 2007
-
-$10.70M(+205.1%)
$29.86M(+16.1%)
Jun 2007
-
-$3.51M(-62.0%)
$25.73M(+200.6%)
Mar 2007
-
-$9.24M(-117.3%)
$8.56M(-62.9%)
Dec 2006
$23.07M(-176.2%)
$53.30M(-459.4%)
$23.07M(-146.1%)
Sep 2006
-
-$14.83M(-28.3%)
-$50.08M(-0.3%)
Jun 2006
-
-$20.68M(-491.7%)
-$50.24M(-13.6%)
Mar 2006
-
$5.28M(-126.6%)
-$58.15M(+91.9%)
Dec 2005
-$30.30M(+79.2%)
-$19.85M(+32.3%)
-$30.30M(+33.8%)
Sep 2005
-
-$15.00M(-47.5%)
-$22.65M(+101.6%)
Jun 2005
-
-$28.58M(-186.3%)
-$11.24M(-132.3%)
Mar 2005
-
$33.13M(-371.6%)
$34.80M(-305.8%)
Dec 2004
-$16.91M(+175.7%)
-$12.20M(+240.2%)
-$16.91M(-49.0%)
Sep 2004
-
-$3.59M(-120.5%)
-$33.14M(-202.7%)
Jun 2004
-
$17.46M(-194.0%)
$32.26M(-224.5%)
Mar 2004
-
-$18.58M(-34.6%)
-$25.91M(+322.4%)
Dec 2003
-$6.13M(-94.5%)
-$28.43M(-146.0%)
-$6.13M(-29.7%)
Sep 2003
-
$61.81M(-251.8%)
-$8.73M(-90.8%)
Jun 2003
-
-$40.71M(-3512.2%)
-$94.39M(+13.4%)
Mar 2003
-
$1.19M(-103.8%)
-$83.28M(-24.7%)
Dec 2002
-$110.52M(+92.8%)
-$31.03M(+30.1%)
-$110.52M(+13.8%)
Sep 2002
-
-$23.85M(-19.4%)
-$97.15M(+2.1%)
Jun 2002
-
-$29.59M(+13.6%)
-$95.19M(+27.0%)
Mar 2002
-
-$26.05M(+47.6%)
-$74.98M(+30.8%)
Dec 2001
-$57.32M(+105.4%)
-$17.65M(-19.4%)
-$57.32M(+32.0%)
Sep 2001
-
-$21.89M(+133.4%)
-$43.44M(+70.1%)
Jun 2001
-
-$9.38M(+11.7%)
-$25.53M(+29.5%)
Mar 2001
-
-$8.40M(+122.7%)
-$19.72M(-29.3%)
Dec 2000
-$27.91M(+106.7%)
-$3.77M(-5.4%)
-$27.91M(+65.7%)
Sep 2000
-
-$3.99M(+11.7%)
-$16.84M(-18.1%)
Jun 2000
-
-$3.57M(-78.5%)
-$20.55M(-5.2%)
Mar 2000
-
-$16.59M(-327.2%)
-$21.69M(+60.6%)
Dec 1999
-$13.50M(+32.4%)
$7.30M(-194.8%)
-$13.50M(-49.1%)
Sep 1999
-
-$7.70M(+63.8%)
-$26.50M(+81.5%)
Jun 1999
-
-$4.70M(-44.0%)
-$14.60M(+1.4%)
Mar 1999
-
-$8.40M(+47.4%)
-$14.40M(+41.2%)
Dec 1998
-$10.20M(+67.2%)
-$5.70M(-235.7%)
-$10.20M(+628.6%)
Sep 1998
-
$4.20M(-193.3%)
-$1.40M(-80.8%)
Jun 1998
-
-$4.50M(+7.1%)
-$7.30M(+5.8%)
Mar 1998
-
-$4.20M(-235.5%)
-$6.90M(+13.1%)
Dec 1997
-$6.10M(-70.0%)
$3.10M(-282.4%)
-$6.10M(-34.4%)
Sep 1997
-
-$1.70M(-58.5%)
-$9.30M(-36.3%)
Jun 1997
-
-$4.10M(+20.6%)
-$14.60M(-11.0%)
Mar 1997
-
-$3.40M(+3300.0%)
-$16.40M(-19.2%)
Dec 1996
-$20.30M(+11.5%)
-$100.00K(-98.6%)
-$20.30M(+12.2%)
Sep 1996
-
-$7.00M(+18.6%)
-$18.10M(-19.2%)
Jun 1996
-
-$5.90M(-19.2%)
-$22.40M(+18.5%)
Mar 1996
-
-$7.30M(-447.6%)
-$18.90M(+3.8%)
Dec 1995
-$18.20M(-11.2%)
$2.10M(-118.6%)
-$18.20M(-42.6%)
Sep 1995
-
-$11.30M(+370.8%)
-$31.70M(+20.5%)
Jun 1995
-
-$2.40M(-63.6%)
-$26.30M(+45.3%)
Mar 1995
-
-$6.60M(-42.1%)
-$18.10M(-11.7%)
Dec 1994
-$20.50M(-31.9%)
-$11.40M(+93.2%)
-$20.50M(+13.3%)
Sep 1994
-
-$5.90M(-201.7%)
-$18.10M(-0.5%)
Jun 1994
-
$5.80M(-164.4%)
-$18.20M(-42.8%)
Mar 1994
-
-$9.00M(0.0%)
-$31.80M(+5.6%)
Dec 1993
-$30.10M(+75.0%)
-$9.00M(+50.0%)
-$30.10M(+11.1%)
Sep 1993
-
-$6.00M(-23.1%)
-$27.10M(+8.8%)
Jun 1993
-
-$7.80M(+6.8%)
-$24.90M(+16.9%)
Mar 1993
-
-$7.30M(+21.7%)
-$21.30M(+23.8%)
Dec 1992
-$17.20M(+152.9%)
-$6.00M(+57.9%)
-$17.20M(+53.6%)
Sep 1992
-
-$3.80M(-9.5%)
-$11.20M(+51.4%)
Jun 1992
-
-$4.20M(+31.3%)
-$7.40M(+131.3%)
Mar 1992
-
-$3.20M
-$3.20M
Dec 1991
-$6.80M
-
-

FAQ

  • What is Regeneron Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual CFO year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly CFO year-on-year change?
  • What is Regeneron Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals TTM CFO year-on-year change?

What is Regeneron Pharmaceuticals annual cash flow from operations?

The current annual CFO of REGN is $4.42B

What is the all time high annual CFO for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual cash flow from operations is $7.08B

What is Regeneron Pharmaceuticals annual CFO year-on-year change?

Over the past year, REGN annual cash flow from operations has changed by -$173.50M (-3.78%)

What is Regeneron Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of REGN is $1.05B

What is the all time high quarterly CFO for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly cash flow from operations is $3.41B

What is Regeneron Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, REGN quarterly cash flow from operations has changed by -$467.40M (-30.90%)

What is Regeneron Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of REGN is $3.95B

What is the all time high TTM CFO for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high TTM cash flow from operations is $8.51B

What is Regeneron Pharmaceuticals TTM CFO year-on-year change?

Over the past year, REGN TTM cash flow from operations has changed by -$785.80M (-16.58%)
On this page